Versant Ventures V (Canada), L.P.

10% owner at Turnstone Biologics Corp. · on record since Jul 27, 2023
10% owner at CRISPR Therapeutics AG · on record since Sep 7, 2017
10% owner at Crinetics Pharmaceuticals, Inc. · on record since Feb 6, 2019
10% owner at Aprea Therapeutics, Inc. · on record since Oct 7, 2019
10% owner at Repare Therapeutics Inc. · on record since Jun 25, 2020

Insider trading activity of Versant Ventures V (Canada), L.P.

No transactions on record for Versant Ventures V (Canada), L.P..

Track record of Versant Ventures V (Canada), L.P.

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Versant Ventures V (Canada), L.P.

Co-insiders of Versant Ventures V (Canada), L.P.

Versant Affiliates Fund V, L.P.Aprea Therapeutics, Inc. +4
Versant Ophthalmic Affiliates I, L.P.Aprea Therapeutics, Inc. +4
Versant Venture Capital V (Canada), LPAprea Therapeutics, Inc. +4
Versant Venture Capital V, L.P.Aprea Therapeutics, Inc. +4
Versant Ventures V, LLCAprea Therapeutics, Inc. +4
ORBIMED ADVISORS LLCCrinetics Pharmaceuticals, Inc. +2
Versant Ventures V GP-GP (Canada), Inc.Aprea Therapeutics, Inc. +2
5AM Co-Investors IV, L.P.Aprea Therapeutics, Inc. +1
5AM Partners IV, LLCAprea Therapeutics, Inc. +1
5AM Ventures IV, L.P.Aprea Therapeutics, Inc. +1
DIEKMAN JOHN DAprea Therapeutics, Inc. +1
Green JeremyAprea Therapeutics, Inc. +1
Jerel DavisRepare Therapeutics Inc. +1
Kulkarni SamarthCRISPR Therapeutics AG +1
Morrison BriggsCRISPR Therapeutics AG +1
OrbiMed Capital GP VI LLCCrinetics Pharmaceuticals, Inc. +1
Redmile Group, LLCAprea Therapeutics, Inc. +1
ROCKLAGE SCOTT MAprea Therapeutics, Inc. +1
Schwab Andrew J.Aprea Therapeutics, Inc. +1
Versant Vantage I GP-GP, LLCAprea Therapeutics, Inc. +1
Versant Vantage I GP, L.P.Aprea Therapeutics, Inc. +1
Versant Vantage I, L.P.Aprea Therapeutics, Inc. +1
5AM Opportunities I (GP), LLCAprea Therapeutics, Inc.
5AM Opportunities I, L.P.Aprea Therapeutics, Inc.
ABBOT STEWARTTurnstone Biologics Corp.
Abrahmsen Lars B.Aprea Therapeutics, Inc.
Alves Sandra Isabelle BarrosRepare Therapeutics Inc.
Attar Eyal C.Aprea Therapeutics, Inc.
Azmat SaryahTurnstone Biologics Corp.
BAYER AKTIENGESELLSCHAFTCRISPR Therapeutics AG
Bayer Global Investments B.V.CRISPR Therapeutics AG
Bedrosian Camille LCrinetics Pharmaceuticals, Inc.
Behbahani AliCRISPR Therapeutics AG
Betz Stephen F.Crinetics Pharmaceuticals, Inc.
BIOTECHNOLOGY VALUE FUND II LPRepare Therapeutics Inc.
BIOTECHNOLOGY VALUE FUND L PRepare Therapeutics Inc.
Biotechnology Value Trading Fund OS LPRepare Therapeutics Inc.
BIZZARI JEAN-PIERREAprea Therapeutics, Inc.
Bolzon Bradley J PhDCRISPR Therapeutics AG
Bonita David PRepare Therapeutics Inc.
Bruno JulianneCRISPR Therapeutics AG
Burgess Michael F.Turnstone Biologics Corp.
BVF GP HOLDINGS LLCRepare Therapeutics Inc.
BVF I GP LLCRepare Therapeutics Inc.
BVF II GP LLCRepare Therapeutics Inc.
BVF INC/ILRepare Therapeutics Inc.
BVF PARTNERS L P/ILRepare Therapeutics Inc.
BVF Partners OS Ltd.Repare Therapeutics Inc.
CAGNONI PABLO JCRISPR Therapeutics AG
Campisi Peter Joseph Jr.Turnstone Biologics Corp.

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →